# A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV

> **NCT04490057** · PHASE4 · COMPLETED · sponsor: **Yale University** · enrollment: 323 (actual)

## Conditions studied

- Tobacco Use Cessation

## Interventions

- **DRUG:** Nicotine patch, nicotine gum, nicotine nasal spray, nicotine inhaler
- **DRUG:** Varenicline or bupropion
- **BEHAVIORAL:** Contingency Management

## Key facts

- **NCT ID:** NCT04490057
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-27
- **Primary completion:** 2024-10-24
- **Final completion:** 2025-10-24
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2026-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04490057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04490057, "A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04490057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*